GLPwatch

Saxenda vs Victoza

Drug comparison

Last updated 2026-05-28 15:46 UTC

Saxenda and Victoza both contain the same active ingredient, liraglutide, and are made by Novo Nordisk, but they are FDA-approved for different uses—Saxenda treats obesity, while Victoza is for type 2 diabetes and reducing cardiovascular risk. Both are taken as daily injections under the skin, but Saxenda is prescribed at a higher dose than Victoza.

AI summary of the sources below.

Saxenda Victoza
Active ingredientliraglutideliraglutide
Manufacturernovo-nordisknovo-nordisk
Routesubcutaneous injectionsubcutaneous injection
FDA-approved forobesitytype 2 diabetes, cardiovascular risk reduction
Label updated2026-02-252023-02-06

Compare full details on the Saxenda and Victoza pages.